tag@treatmentactiongroup.org

HIV

Reconsideration of support for impending 21st Century Cures Act

  • Chad Cipiti
Dear Minority Leader Pelosi: On behalf of Treatment Action Group (TAG), I write to you strongly urging for the reconsideration of your support for the passage of the 21st Century Cures Act. Even as an impending and new version of the bill is set to be introduced by Energy and Commerce Chairman, Rep. Fred Upton – we are concerned that several provisions carried from the prior iteration of the bill (H.R. 6) may continue to undermine public health and jeopardize patient safety. These concerns include lowering standards for the FDA in determining approval for prospective drugs and devices, increasing the likelihood of antimicrobial resistance, to granting extended market exclusivity for new drugs.
Read more

TAGline Fall 2016

  • Chad Cipiti
Health, Human Rights, and Social Justice: maximizing HIV, tuberculosis (TB), and viral hepatitis outcomes depends on the availability of state-of-the-art diagnostic and prognostic tools, engagement in expert and supportive care, and access to safe and effective drugs.
Read more

Toward Health Equity

  • Chad Cipiti

We will not end HIV as an epidemic without the expertise and leadership of Black and Latino gay and bisexual men and transgender people of color. By Jeremiah Johnson In February 2016, the CDC issued a new report with a…

Read more

Countering the Contagion of Racism Through Resistance

  • Chad Cipiti

Upholding narratives of Black science and treatment activism, and community mobilization in HIV/AIDS and TB By Suraj Madoori In February 2016, startling data released by the Centers for Disease Control and Prevention (CDC) at the Conference of Retroviruses and Opportunistic…

Read more

Story: British Scientists on Brink of HIV Cure

  • Dorrit Walsh

October 2016 Examples of media coverage:  British scientists on brink of HIV cure (headline now corrected to “British scientists hopeful for HIV cure”) – The Sunday Times, October 2, 2016 (registration required) HIV cure close after disease ‘vanishes’ from blood of British man (now…

Read more

The Stigma of HIV Prevention

  • Chad Cipiti

July 13, 2016 The consequences of stigma among people living with and vulnerable to HIV infection are significant and far-reaching. Stigma is frequently cited as a significant barrier to successful pre-exposure prophylaxis (PrEP) awareness, access and utilization. Despite having been…

Read more

Improving Health Outcomes in HIV Immunologic Non-Responders

  • Dorrit Walsh
A conference call meeting initiated by HIV community advocates was held with FDA members on June 10, 2016 to discuss ways to advance the evaluation and development of products (drugs or biologics) that demonstrate promise in improving health outcomes in HIV-positive patients with inadequate immune response after long term successful HIV treatment.
Read more

An Open Letter to Senator Sanders Challenging the Characterization of Meeting with HIV/AIDS Activists

  • Chad Cipiti
Dear Senator Sanders: We are grateful that you took time to sit with us this week to discuss a broad range of issues related to the fight against HIV/AIDS. Our group represents a larger coalition of over 70 organizations and advocates from across the country who hope to use this opportunity to push forward the national conversation, which is sorely missing, about HIV/AIDS. While we were optimistic following what we felt was a productive meeting, our optimism quickly turned to disappointment when your campaign issued a news release misrepresenting the meeting with HIV/AIDS leadership entitled “Sanders Backs California Ballot Initiative to Rein in Drug Prices at Meeting with HIV/AIDS Advocates.”
Read more

Story: Cure for HIV Possible “Within Three Years”

  • Dorrit Walsh

April 2016 The Daily Telegraph article and examples of the media coverage that followed it: Cure for HIV possible within three years as scientists snip virus from cells– The Daily Telegraph, April 1, 2016. Update April 6, 2016: After receiving complaints, The Daily…

Read more

The Low Cost of Universal Access

  • Chad Cipiti

Generic treatments for HIV, viral hepatitis, and cancer can be affordably—and profitably—mass-produced for broad, unobstructed availability By Tracy Swan TAG talks with Andrew Hill, senior visiting research fellow in the University of Liverpool’s Department of Pharmacology, about his group’s work…

Read more
Back To Top